{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:38:10Z","timestamp":1789562290746,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00535-020-01663-1","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T10:02:50Z","timestamp":1578909770000},"page":"523-532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort"],"prefix":"10.1007","volume":"55","author":[{"given":"Zeinab","family":"Bakhshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira B.","family":"Hilscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Gores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason K.","family":"Viehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas F.","family":"LaRusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea A.","family":"Gossard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos N.","family":"Lazaridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith D.","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,13]]},"reference":[{"key":"1663_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","volume":"145","author":"JE Eaton","year":"2013","unstructured":"Eaton JE, Talwalkar JA, Lazaridis KN, et al. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology. 2013;145:521\u201336.","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"1663_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000440823","volume":"33","author":"CY Ponsioen","year":"2015","unstructured":"Ponsioen CY. Diagnosis, differential diagnosis, and epidemiology of primary sclerosing cholangitis. Dig Dis. 2015;33(Suppl 2):134\u20139.","journal-title":"Dig Dis."},{"key":"1663_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/bmb\/ldv019","volume":"114","author":"KD Williamson","year":"2015","unstructured":"Williamson KD, Chapman RW. Primary sclerosing cholangitis: a clinical update. Br Med Bull. 2015;114:53\u201364.","journal-title":"Br Med Bull."},{"key":"1663_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.jhep.2008.02.017","volume":"48","author":"TR Card","year":"2008","unstructured":"Card TR, Solaymani-Dodaran M, West J. Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study. J Hepatol. 2008;48:939\u201344.","journal-title":"J Hepatol."},{"key":"1663_CR5","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1111\/jgh.13774","volume":"32","author":"JE Eaton","year":"2017","unstructured":"Eaton JE, McCauley BM, Atkinson EJ, et al. Variations in primary sclerosing cholangitis across the age spectrum. J Gastroenterol Hepatol. 2017;32:1763\u20138.","journal-title":"J Gastroenterol Hepatol."},{"key":"1663_CR6","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","volume":"152","author":"TJ Weismuller","year":"2017","unstructured":"Weismuller TJ, Trivedi PJ, Bergquist A, et al. Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis. Gastroenterology. 2017;152:1975.","journal-title":"Gastroenterology"},{"key":"1663_CR7","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","volume":"56","author":"K Boonstra","year":"2012","unstructured":"Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012;56:1181\u20138.","journal-title":"J Hepatol."},{"key":"1663_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/liv.13328","volume":"37","author":"K Liu","year":"2017","unstructured":"Liu K, Wang RX, Kariyawasam V, et al. Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort. Liver Int. 2017;37:442\u20138.","journal-title":"Liver Int."},{"key":"1663_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1136\/gut.51.4.562","volume":"51","author":"CY Ponsioen","year":"2002","unstructured":"Ponsioen CY, Vrouenraets SM, Prawirodirdjo W, et al. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut. 2002;51:562\u20136.","journal-title":"Gut"},{"key":"1663_CR10","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/hep.26565","volume":"58","author":"K Boonstra","year":"2013","unstructured":"Boonstra K, Weersma RK, van Erpecum KJ, et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology. 2013;58:2045\u201355.","journal-title":"Hepatology"},{"key":"1663_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.dld.2010.12.008","volume":"43","author":"PP Stanich","year":"2011","unstructured":"Stanich PP, Bjornsson E, Gossard AA, et al. Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis. Dig Liver Dis. 2011;43:309\u201313.","journal-title":"Dig Liver Dis."},{"key":"1663_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jhep.2012.10.013","volume":"58","author":"S Al Mamari","year":"2013","unstructured":"Al Mamari S, Djordjevic J, Halliday JS, et al. Improvement of serum alkaline phosphatase to %3c 1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol. 2013;58:329\u201334.","journal-title":"J Hepatol"},{"key":"1663_CR13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.cgh.2012.12.032","volume":"11","author":"L Lindstrom","year":"2013","unstructured":"Lindstrom L, Hultcrantz R, Boberg KM, et al. Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol. 2013;11:841\u20136.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"1663_CR14","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/apt.12979","volume":"40","author":"C Rupp","year":"2014","unstructured":"Rupp C, Rossler A, Halibasic E, et al. Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis. Aliment Pharmacol Ther. 2014;40:1292\u2013301.","journal-title":"Aliment Pharmacol Ther."},{"key":"1663_CR15","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1111\/liv.13110","volume":"36","author":"EM de Vries","year":"2016","unstructured":"de Vries EM, Wang J, Leeflang MM, et al. Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value. Liver Int. 2016;36:1867\u201375.","journal-title":"Liver Int."},{"key":"1663_CR16","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/hep.28256","volume":"63","author":"CY Ponsioen","year":"2016","unstructured":"Ponsioen CY, Chapman RW, Chazouilleres O, et al. Surrogate endpoints for clinical trials in primary sclerosing cholangitis: review and results from an International PSC Study Group consensus process. Hepatology. 2016;63:1357\u201367.","journal-title":"Hepatology"},{"key":"1663_CR17","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/hep.30479","volume":"69","author":"EC Goode","year":"2019","unstructured":"Goode EC, Clark AB, Mells GF, et al. Factors associated with outcomes of patients with primary sclerosing cholangitis and development and validation of a risk scoring system. Hepatology. 2019;69:2120\u201335.","journal-title":"Hepatology"},{"key":"1663_CR18","first-page":"246","volume":"15","author":"M Hilscher","year":"2016","unstructured":"Hilscher M, Enders FB, Carey EJ, et al. Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis. Ann Hepatol. 2016;15:246\u201353.","journal-title":"Ann Hepatol."},{"key":"1663_CR19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s10654-013-9873-0","volume":"29","author":"LC Thygesen","year":"2014","unstructured":"Thygesen LC, Ersboll AK. When the entire population is the sample: strengths and limitations in register-based epidemiology. Eur J Epidemiol. 2014;29:551\u20138.","journal-title":"Eur J Epidemiol."},{"key":"1663_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-230X-11-83","volume":"11","author":"E Toy","year":"2011","unstructured":"Toy E, Balasubramanian S, Selmi C, et al. The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population. BMC Gastroenterol. 2011;11:83.","journal-title":"BMC Gastroenterol."},{"key":"1663_CR21","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","volume":"125","author":"K Bambha","year":"2003","unstructured":"Bambha K, Kim WR, Talwalkar J, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology. 2003;125:1364\u20139.","journal-title":"Gastroenterology"},{"key":"1663_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4065\/71.3.266","volume":"3","author":"LJ Melton III","year":"1996","unstructured":"Melton LJ III. History of the Rochester epidemiology project. Mayo Clin Proc. 1996;3:266\u201374.","journal-title":"Mayo Clin Proc."},{"key":"1663_CR23","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/hep.23294","volume":"51","author":"R Chapman","year":"2010","unstructured":"Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660\u201378.","journal-title":"Hepatology"},{"key":"1663_CR24","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"TH Karlsen","year":"2017","unstructured":"Karlsen TH, Folseraas T, Thorburn D, et al. Primary sclerosing cholangitis\u2014a comprehensive review. J Hepatol. 2017;67:1298\u2013323.","journal-title":"J Hepatol."},{"key":"1663_CR25","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.cgh.2015.05.035","volume":"13","author":"S Rizvi","year":"2015","unstructured":"Rizvi S, Eaton JE, Gores GJ. Primary sclerosing cholangitis as a premalignant biliary tract disease: surveillance and management. Clin Gastroenterol Hepatol. 2015;13:2152\u201365.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"1663_CR26","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","volume":"7","author":"WR Kim","year":"2000","unstructured":"Kim WR, Therneau TM, Wiesner RH, et al. A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc. 2000;7:688\u201394.","journal-title":"Mayo Clin Proc."},{"key":"1663_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30085","author":"JE Eaton","year":"2018","unstructured":"Eaton JE, Vesterhus M, McCauley BM, et al. Primary sclerosing cholangitis risk estimate tool (PREsTo) predicts outcomes of the disease: a derivation and validation study using machine learning. Hepatology. 2018. https:\/\/doi.org\/10.1002\/hep.30085.","journal-title":"Hepatology."},{"key":"1663_CR28","first-page":"101","volume":"6","author":"F Ederer","year":"1961","unstructured":"Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961;6:101\u201321.","journal-title":"Natl Cancer Inst Monogr."},{"key":"1663_CR29","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.cgh.2016.10.039","volume":"15","author":"R Shivashankar","year":"2017","unstructured":"Shivashankar R, Tremaine WJ, Harmsen WS, et al. Incidence and prevalence of Crohn\u2019s disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010. Clin Gastroenterol Hepatol. 2017;15:857\u201363.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"1663_CR30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/hep.23678","volume":"52","author":"B Lindkvist","year":"2010","unstructured":"Lindkvist B, de Valle MB, Gullberg B, et al. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden. Hepatology. 2010;52:571\u20137.","journal-title":"Hepatology"},{"issue":"7","key":"1663_CR31","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.cgh.2018.04.047","volume":"17","author":"A Kuo","year":"2019","unstructured":"Kuo A, Gomel R, Safer R, Lindor KD, Everson GT, Bowlus CL. Characteristics and outcomes reported by patients with primary sclerosing cholangitis through an online registry. Clin Gastroenterol Hepatol. 2019;17(7):1372\u20138.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"1663_CR32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOG.0000000000000333","volume":"33","author":"WR Takakura","year":"2017","unstructured":"Takakura WR, Tabibian JH, Bowlus CL. The evolution of natural history of primary sclerosing cholangitis. Curr Opin Gastroenterol. 2017;33:71\u20137.","journal-title":"Curr Opin Gastroenterol."},{"key":"1663_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","volume":"102","author":"JJ Tischendorf","year":"2007","unstructured":"Tischendorf JJ, Hecker H, Kruger M, et al. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am J Gastroenterol. 2007;102:107\u201314.","journal-title":"Am J Gastroenterol."}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-020-01663-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-020-01663-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-020-01663-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T22:25:20Z","timestamp":1610490320000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-020-01663-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,13]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1663"],"URL":"https:\/\/doi.org\/10.1007\/s00535-020-01663-1","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,13]]},"assertion":[{"value":"7 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}